VISTEON CORP (VC)

Recent earnings expectations and fresh store openings have put CVS Health (CVS) in focus for investors. The stock now sits near US$105 after a strong past year, raising questions about what is already reflected in the price. See our latest analysis for CVS Health.

Verizon’s second quarter was met with a positive market reaction, despite revenue coming in below Wall Street expectations. Management credited improved customer additions and reduced churn for the company’s solid operational performance. CEO Dan Schulman highlighted that postpaid phone ...

Beyond analysts' top-and-bottom-line estimates for CVS Health (CVS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.

Chevron saw profits surge in the second quarter on soaring prices for refined products.

VICI Properties (VICI) drew investor attention after reporting second quarter 2026 earnings. Revenue reached US$1.06b, above Wall Street estimates, while funds from operations and earnings per share were broadly in line with expectations. See our latest analysis for VICI Properties.